Ozempic, Mounjaro, and Zepbound can drive impressive weight loss, but stopping them is often followed by rapid weight regain.

Ozempic, a semaglutide drug originally developed for type-2 diabetes, has been in the news as a fast-track weight-loss ...

We’ve all heard of Ozempic by now. It’s only licensed for use as a diabetes treatment in the UK and US, but it's widely used ‘off label’ to help people lose weight. So much so, in fact, that its name ...

A new randomized trial shows that GLP-1 weight-loss drugs like liraglutide help reduce weight but don't improve physical ...

Amy Schumer shares the truth behind her weight loss journey, from struggling with Ozempic’s side effects to finding success ...

Semaglutide — the active ingredient in Ozempic® — can reduce systolic blood pressure by about 5 mm Hg and diastolic blood pressure by about 2.5 mm Hg. It’s unclear if semaglutide can lower blood ...

Eli Lilly and Company announced promising results for its next-generation weight-loss drug Thursday, with patients losing up to 20.1 percent of their body weight on eloralintide. The once-weekly ...

Brace yourselves, Ozempic and Zepbound. Eli Lilly just released a jaw-dropping sneak peek from the final phases of testing for retatrutide (nicknamed "Reta"), a brand new GLP-1 weight loss drug that ...

Monthly injections, once-daily pills, and even lifelong gene therapies could soon become options for people looking to lose ...